Hospice News January 8, 2026
Hospice merger and acquisition (M&A) activity is anticipated to be more effervescent in 2026 compared to a slow-churning quagmire that marked most of last year. Compliance, quality and care collaboration are among the significant propellants in strategic deal-making.
Hospice News recently sat down with a mix of hospice providers and health care consulting and M&A advisory firms to examine the key considerations in deal-making this year.
Important factors in hospice transactions include considerations around sustainability, program integrity, technology investment and navigating changes in regulation, reimbursement and patient needs.
Hospices’ strategic focal points
Hospices’ greatest strategic opportunities in 2026 will come from partnerships that strengthen continuity across the care continuum, according to Andy Johnston, president of hospice, palliative and personal care...







